catechin has been researched along with Staphylococcal Infections in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (20.00) | 29.6817 |
| 2010's | 9 (45.00) | 24.3611 |
| 2020's | 7 (35.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, N; Hao, K; Liu, C; Liu, Z | 1 |
| Sinsinwar, S; Vadivel, V | 1 |
| Brito, M; Delgadinho, M; Mira, AR; Ponte, T; Ribeiro, E; Zeferino, AS | 1 |
| Jayaraman, A; Mahapatra, SK; Sinsinwar, S; Vellingiri, V | 1 |
| Dobrzynska, I; Lapshina, EA; Olchowik-Grabarek, E; Roszkowska, A; Sekowski, S; Veiko, AG; Zamaraeva, M; Zavodnik, IB | 1 |
| Chen, H; Chen, R; Cui, M; Dong, Z; Feng, Y; Li, Y; Liu, W; Sun, S; Wang, J; Ye, H; Zhang, Q; Zhang, Y; Zheng, T | 1 |
| Deng, X; Guo, Y; Liu, X; Niu, X; Teng, Z; Wang, J; Yu, Q; Zhang, J | 1 |
| Hu, C; Kong, Q; Lu, Y; Luo, R; Wang, Y; Wu, C; Zhang, B; Zhang, F | 1 |
| Bao, GH; Gaur, R | 1 |
| Chen, C; Deng, X; Pan, J; Wang, J; Zhou, Y | 1 |
| Liu, B; Wang, M; Wang, X | 1 |
| Fan, S; Li, J; Li, W; Sama, AE; Tracey, KJ; Tsai, S; Wang, H; Wang, P; Zhao, L; Zhu, S | 1 |
| Abreu, AC; Borges, A; Mcbain, AJ; Saavedra, MJ; Salgado, AJ; Serra, SC; Simões, M | 1 |
| Dziedzic, A; Idzik, D; Kępa, M; Miklasińska, M; Wąsik, TJ; Wojtyczka, RD | 1 |
| Faezizadeh, Z; Gharib, A; Godarzee, M | 1 |
| Jiang, W; Li, B; Peng, W; Qin, R; Xiao, K; Zheng, J; Zhou, H | 1 |
| Atsumi, T; Hara, Y; Kosuge, K; Li, XD; Nishio, S; Ohashi, K; Okabe, H; Shimizu, T; Watanabe, H; Yamada, H | 1 |
| Atsumi, T; Hara, Y; Harada, K; Iijima, H; Komagata, Y; Komiyama, K; Ohashi, K; Ohashi, T; Shimizu, T; Tateishi, M; Watanabe, H; Yamada, H | 1 |
| Ziment, I | 1 |
| Ishida, I; Kohda, C; Miyaoka, H; Shimamura, T; Yanagawa, Y | 1 |
2 review(s) available for catechin and Staphylococcal Infections
| Article | Year |
|---|---|
Chemistry and Pharmacology of Natural Catechins from Camellia sinensis as Anti-MRSA Agents.
Topics: Anti-Bacterial Agents; Camellia sinensis; Catechin; Humans; Methicillin-Resistant Staphylococcus aureus; Phytochemicals; Polyphenols; Staphylococcal Infections; Tea | 2021 |
Time for tea?
Topics: Administration, Inhalation; Antioxidants; Catechin; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Tea | 2006 |
2 trial(s) available for catechin and Staphylococcal Infections
| Article | Year |
|---|---|
Effects of tea catechin inhalation on methicillin-resistant Staphylococcus aureus in elderly patients in a hospital ward.
Topics: Activities of Daily Living; Administration, Inhalation; Aged; Aged, 80 and over; Carrier State; Catechin; Cross Infection; Female; Geriatric Assessment; Hospital Units; Humans; Japan; Length of Stay; Male; Methicillin Resistance; Sputum; Staphylococcal Infections; Staphylococcus aureus; Tea; Time Factors; Treatment Outcome | 2003 |
A randomized clinical study of tea catechin inhalation effects on methicillin-resistant Staphylococcus aureus in disabled elderly patients.
Topics: Administration, Inhalation; Aged; Aged, 80 and over; Catechin; Cerebrovascular Disorders; Chi-Square Distribution; Colony Count, Microbial; Disabled Persons; Drug Administration Schedule; Female; Frail Elderly; Hospitals, General; Humans; Japan; Male; Methicillin Resistance; Prospective Studies; Single-Blind Method; Sputum; Staphylococcal Infections; Staphylococcus aureus; Tea; Treatment Outcome | 2006 |
16 other study(ies) available for catechin and Staphylococcal Infections
| Article | Year |
|---|---|
Epigallocatechin gallate (EGCG) attenuates staphylococcal alpha-hemolysin (Hla)-induced NLRP3 inflammasome activation via ROS-MAPK pathways and EGCG-Hla interactions.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Bacterial Proteins; Catechin; Disease Models, Animal; Hemolysin Proteins; Hemolysis; Humans; Inflammasomes; Male; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Reactive Oxygen Species; Signal Transduction; Staphylococcal Infections; Staphylococcus aureus; THP-1 Cells | 2021 |
Development and characterization of catechin-in-cyclodextrin-in-phospholipid liposome to eradicate MRSA-mediated surgical site infection: Investigation of their anti-infective efficacy through in vitro and in vivo studies.
Topics: Animals; Anti-Bacterial Agents; Catechin; Cyclodextrins; Liposomes; Methicillin-Resistant Staphylococcus aureus; Mice; Phospholipids; Staphylococcal Infections; Surgical Wound Infection | 2021 |
Drug Resistance and Epigenetic Modulatory Potential of Epigallocatechin-3-Gallate Against Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Catechin; Drug Resistance; Epigenesis, Genetic; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus | 2022 |
Anti-virulence properties of catechin-in-cyclodextrin-in-phospholipid liposome through down-regulation of gene expression in MRSA strains.
Topics: Anti-Bacterial Agents; Biofilms; Catechin; Cyclodextrins; Down-Regulation; Humans; Hydrogen Peroxide; Liposomes; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phospholipids; Staphylococcal Infections; Virulence; Virulence Factors | 2022 |
Antimicrobial Activity of Quercetin, Naringenin and Catechin: Flavonoids Inhibit
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Catechin; Erythrocytes; Flavonoids; Hemolysis; Quercetin; Sheep; Staphylococcal Infections; Staphylococcus aureus | 2023 |
Co-assembled nanocomplexes comprising epigallocatechin gallate and berberine for enhanced antibacterial activity against multidrug resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Berberine; Catechin; Methicillin-Resistant Staphylococcus aureus; Mice; Nanocomposites; Staphylococcal Infections; Staphylococcus aureus | 2023 |
Theaflavin-3,3´-digallate increases the antibacterial activity of β-lactam antibiotics by inhibiting metallo-β-lactamase activity.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Biflavonoids; Binding Sites; Catechin; Cephalothin; Female; Hydrolysis; Methicillin-Resistant Staphylococcus aureus; Mice, Inbred BALB C; Microbial Sensitivity Tests; Models, Molecular; Pneumonia; Staphylococcal Infections | 2019 |
Synergistic Chemical and Photodynamic Antimicrobial Therapy for Enhanced Wound Healing Mediated by Multifunctional Light-Responsive Nanoparticles.
Topics: Animals; Anti-Infective Agents; Catechin; Cell Line; Chlorophyllides; Delayed-Action Preparations; Escherichia coli; Magnesium; Mice; Nanoparticles; Photochemotherapy; Porphyrins; Rats; Staphylococcal Infections; Staphylococcus aureus; Wound Healing; Wound Infection | 2019 |
Epigallocatechin gallate can attenuate human alveolar epithelial cell injury induced by alpha-haemolysin.
Topics: A549 Cells; Alveolar Epithelial Cells; Bacterial Toxins; Catechin; Cell Line; Hemolysin Proteins; Hemolysis; Humans; Microbial Sensitivity Tests; Protein Multimerization; Staphylococcal Infections; Staphylococcus aureus; Virulence | 2018 |
Phytochemical analysis and antibacterial activity of methanolic extract of Bergenia purpurascens against common respiratory infection causing bacterial species in vitro and in neonatal rats.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antioxidants; Bacteria; Benzopyrans; Catechin; Disease Models, Animal; Drugs, Chinese Herbal; Flavanones; Gallic Acid; Methanol; Microbial Sensitivity Tests; Phytochemicals; Plant Extracts; Plant Leaves; Rats; Respiratory Tract Infections; Saxifragaceae; Staphylococcal Infections; Staphylococcus aureus | 2018 |
Green tea catechins quench the fluorescence of bacteria-conjugated Alexa fluor dyes.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Catechin; Cells, Cultured; Coinfection; Escherichia coli; Escherichia coli Infections; Fluorescence; Humans; Hydrazines; Injections, Intraperitoneal; Mice; Mice, Inbred BALB C; Organic Chemicals; Staphylococcal Infections; Staphylococcus aureus; Theaceae | 2013 |
Combinatorial Activity of Flavonoids with Antibiotics Against Drug-Resistant Staphylococcus aureus.
Topics: Ampicillin; Anti-Bacterial Agents; Catechin; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Erythromycin; Flavonoids; Hesperidin; Humans; Microbial Sensitivity Tests; Oxacillin; Quercetin; Rutin; Staphylococcal Infections; Staphylococcus aureus; Tetracycline | 2015 |
Catechin Hydrate Augments the Antibacterial Action of Selected Antibiotics against Staphylococcus aureus Clinical Strains.
Topics: Anti-Bacterial Agents; Catechin; Clindamycin; Drug Synergism; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2016 |
Therapeutic efficacy of epigallocatechin gallate-loaded nanoliposomes against burn wound infection by methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Burns; Catechin; Kidney; Liposomes; Liver; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Nanostructures; Skin; Spleen; Staphylococcal Infections; Wound Infection | 2013 |
The combination of catechin and epicatechin callate from Fructus Crataegi potentiates beta-lactam antibiotics against methicillin-resistant staphylococcus aureus (MRSA) in vitro and in vivo.
Topics: Animals; Anti-Bacterial Agents; Catechin; Crataegus; Drug Therapy, Combination; Methicillin-Resistant Staphylococcus aureus; Mice; Oxacillin; Sepsis; Staphylococcal Infections | 2013 |
Epigallocatechin gallate suppresses expression of receptor activator of NF-kappaB ligand (RANKL) in Staphylococcus aureus infection in osteoblast-like NRG cells.
Topics: Animals; Catechin; Cytokines; Mice; Osteoblasts; Protease Inhibitors; RANK Ligand; Staphylococcal Infections; Staphylococcus aureus | 2007 |